Adult Stem Cells Restore Sight
Three people in Australia have regained their sight after receiving a novel type of adult stem cell therapy.
June 5, 2009
Three people in Australia have regained their sight after receiving a novel type of adult stem cell therapy.
Nearly 50,000 people have submitted their opinions to the National Institutes of Health regarding the new stem cell guidelines.
Mesenchymal stem cells from Wharton’s jelly are found to improve pulmonary fibrosis.
As scientists await the final version of the NIH stem cell guidelines, expected in early July, the draft already proposed continues to attract debate.
The Madison, Wisconsin stem cell startup company, Cellular Dynamics, has announced the licensing of cardiovascular cells from New York’s Mount Sinai Medical School.
The adult stem cell company Fate Therapeutics announces treatment of the first patient in a Phase 1b clinical trial for hematopoietic stem cell support.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.